Tag: Antibiotic selection

According to the Centers for Disease Control and Prevention (CDC), improving antibiotic selection for common conditions is a key initiative to combat antibiotic resistance. When treating a bacterial infection, healthcare providers rely on established protocols that designate what is a first line antibiotic to ensure effective treatment and preserve the potency of more advanced drugs.

Originally isolated from the bacterium *Streptomyces alboniger*, the aminonucleoside antibiotic puromycin is primarily known for its potent ability to inhibit protein synthesis in both prokaryotic and eukaryotic cells, a discovery that has made it an indispensable tool for molecular and cellular biology research.